Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTT-654 in Untreated or Metformin-treated Type 2 Diabetic Patients
NCT00997152Phase 2Terminated
- Sponsor
- Akros Pharma Inc.
- Start
- Sep 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JTT-654 in type 2 diabetes mellitus (T2DM), sponsored by Akros Pharma Inc.. Started Sep 2009; status: terminated.
02
Drugs
JTT-654
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00997152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00997152.